Subdermal Atrophy as an Adverse Event after Glucocorticoid- Based Injection Face Modelling

Subcutaneous injections of glucocorticoids (glucocorticosteroids, GCS) are increasingly used to face modelling. This carries a high risk of soft tissue atrophy. Aim: This report discusses soft tissue atrophy mechanisms after GCS-injection, describes risk factors and treatment regimens. Material and methods: The clinical case of treatment of subcutaneous atrophy that occurred after injection of GCS into malar fat pads is presented. Three-stage treatment of atrophy is described. Results: Аtrophy lesion was eliminated as well as volume-deficient facial areas were filled up. The patient was satisfied with the final result. Conclusions: In aesthetic medicine, GCS should not be applied for intradermal and subcutaneous facial injections due to extremely high risk of dermal and subdermal atrophy.